June 9, 2020 / 5:54 AM / 24 days ago

BRIEF-Sensorion Announces Positive Data From Gene Therapy Programme

June 9 (Reuters) - SENSORION SA:

* SENSORION ANNOUNCES POSITIVE PRELIMINARY PRECLINICAL DATA FROM ITS OTOFERLIN GENE THERAPY PROGRAM

* IN VIVO EXPERIMENTS CONDUCTED SAFELY IN NON-HUMAN PRIMATES SHOW PROMISING PRELIMINARY DATA ON INNER EAR TISSUE TROPISM AND ACHIEVEMENT OF A HIGH TRANSDUCTION RATE EFFICIENCY

* FRENCH GOVERNMENT AWARDED UP TO EUR 9.7 MLN TO “AUDINNOVE” CONSORTIUM TO SUPPORT DEVELOPMENT OF OTOF PROGRAM INTO HUMAN CLINICAL TRIALS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below